Viking Therapeutics Inc (VKTX)
68.86
+3.79
(+5.82%)
USD |
NASDAQ |
Apr 25, 16:00
69.59
+0.73
(+1.06%)
Pre-Market: 09:24
Viking Therapeutics Market Cap: 7.593B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 7.593B |
| April 24, 2024 | 7.175B |
| April 23, 2024 | 7.160B |
| April 22, 2024 | 7.041B |
| April 19, 2024 | 6.993B |
| April 18, 2024 | 7.131B |
| April 17, 2024 | 7.330B |
| April 16, 2024 | 7.493B |
| April 15, 2024 | 7.382B |
| April 12, 2024 | 7.564B |
| April 11, 2024 | 7.812B |
| April 10, 2024 | 7.898B |
| April 09, 2024 | 8.028B |
| April 08, 2024 | 8.364B |
| April 05, 2024 | 8.427B |
| April 04, 2024 | 8.122B |
| April 03, 2024 | 8.646B |
| April 02, 2024 | 8.526B |
| April 01, 2024 | 8.763B |
| March 28, 2024 | 9.038B |
| March 27, 2024 | 9.173B |
| March 26, 2024 | 8.897B |
| March 25, 2024 | 7.616B |
| March 22, 2024 | 7.655B |
| March 21, 2024 | 7.770B |
| Date | Value |
|---|---|
| March 20, 2024 | 7.819B |
| March 19, 2024 | 7.174B |
| March 18, 2024 | 6.973B |
| March 15, 2024 | 6.886B |
| March 14, 2024 | 7.114B |
| March 13, 2024 | 7.869B |
| March 12, 2024 | 7.338B |
| March 11, 2024 | 6.938B |
| March 08, 2024 | 7.850B |
| March 07, 2024 | 8.092B |
| March 06, 2024 | 9.971B |
| March 05, 2024 | 9.612B |
| March 04, 2024 | 9.989B |
| March 01, 2024 | 8.685B |
| February 29, 2024 | 7.853B |
| February 28, 2024 | 9.631B |
| February 27, 2024 | 8.668B |
| February 26, 2024 | 3.867B |
| February 23, 2024 | 3.760B |
| February 22, 2024 | 3.583B |
| February 21, 2024 | 3.535B |
| February 20, 2024 | 3.591B |
| February 16, 2024 | 3.638B |
| February 15, 2024 | 3.201B |
| February 14, 2024 | 3.239B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
163.26M
Minimum
Jun 16 2022
9.989B
Maximum
Mar 04 2024
941.43M
Average
497.29M
Median
Sep 14 2021
Market Cap Benchmarks
| Eli Lilly and Co | 689.18B |
| Pfizer Inc | 142.64B |
| Madrigal Pharmaceuticals Inc | 3.868B |
| Akero Therapeutics Inc | 1.305B |
| Terns Pharmaceuticals Inc | 299.98M |
Market Cap Related Metrics
| Price to Book Value | 8.131 |
| Price | 68.86 |
| Earnings Yield | -1.35% |